A study published in the journal Epilepsy Research shows a reduction in seizure frequency in patients taking the anti-epileptic drug Keppra (levetiracetam).
Researchers from Sahlgren University Hospital in Gothenburg studied 1,422 adults with difficult to control epilepsy who were prescribed the drug. Over a third of patients saw a 50 per cent reduction in the number of seizures and a fifth of patients had a 75 per cent reduction.
The study also showed that a tendency towards a reduction of the number of different anti-epileptic drugs (AEDs) taken by patients. 14 per cent of patients were taking less AEDs at the end of the study period and 5 per cent were taking Keppra only.
Lead investigator Professor Elinor Ben-Menachem commented:
"Seizure control, reduction and elimination are the key concerns for epileptologists and neurologists. Those new data show that levetiracetam could help doctors and patients achieve these goals. Levetiracetam represents a strong treatment option for many patients with epilepsy."